← Back to directory

Emad A. Rakha

Researcher Next ID · RN-023410

Researcher · Biochemistry, Genetics and Molecular Biology

Nottingham University Hospitals NHS Trust

Nottingham, United Arab Emirates

Not currently recruitingFunding unknown
Works count
934
Citation count
36,472
H-index
87
i10-index
467

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Breast Cancer Treatment Studies
Breast Lesions and Carcinomas
HER2/EGFR in Cancer Research
Cancer Cells and Metastasis
Cancer Genomics and Diagnostics

Publications

  • Breast tumor microenvironment structures are associated with genomic features and clinical outcome

    Nature Genetics · 2022 · 10.1038/s41588-022-01041-y

  • IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis

    Cancer Cell · 2020 · 10.1016/j.ccell.2020.06.007

  • A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

    Modern Pathology · 2018 · https://doi.org/10.1038/s41379-018-0110-y

  • An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation

    Breast Cancer Research · 2017 · 10.1186/s13058-017-0852-3

  • Phyllodes tumours of the breast: a consensus review

    Histopathology · 2015 · 10.1111/his.12876

  • Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Annals of Oncology · 2014 · 10.1093/annonc/mdu191

  • Updated UK Recommendations for HER2 assessment in breast cancer

    Journal of Clinical Pathology · 2014 · 10.1136/jclinpath-2014-202571

  • Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

    Breast Cancer Research · 2013 · 10.1186/bcr3493

  • The prognostic significance of lymphovascular invasion in invasive breast carcinoma

    Cancer · 2011 · 10.1002/cncr.26711

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Modern Pathology · 2010 · https://doi.org/10.1038/modpathol.2010.200

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Breast Cancer Research · 2010 · https://doi.org/10.1186/bcr2607

  • Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

    PLoS Medicine · 2010 · https://doi.org/10.1371/journal.pmed.1000279

  • Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

    Breast Cancer Research and Treatment · 2009 · 10.1007/s10549-009-0345-x

  • Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

    Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-2132

  • Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

    Cancer Research · 2009 · 10.1158/0008-5472.can-08-3907

  • Triple-negative/basal-like breast cancer: review

    Pathology · 2008 · 10.1080/00313020802563510

  • Basal-Like Breast Cancer: A Critical Review

    Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.13.1748

  • Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

    Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.15.5986

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.12.2747

  • Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes

    European Journal of Cancer · 2007 · 10.1016/j.ejca.2007.10.009

  • Prognostic markers in triple‐negative breast cancer

    Cancer · 2006 · 10.1002/cncr.22381

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

    The Journal of Pathology · 2006 · 10.1002/path.1916

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    International Journal of Cancer · 2005 · 10.1002/ijc.21004

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

    Modern Pathology · 2005 · 10.1038/modpathol.3800445

  • Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

    Modern Pathology · 2004 · 10.1038/modpathol.3800255

Current projects

    No projects listed.